What does Gentherm do and what are its main business segments?

What factors drove the changes in Gentherm's revenue and profit?

What were the key takeaways from Gentherm's earnings call?

What is the market's earnings forecast for Gentherm next quarter?

What were the key takeaways from Gentherm’s earnings call?

What is the revenue and EPS growth rate for Gentherm year over year?

What guidance did Gentherm's management provide for the next earnings period?

Did Gentherm beat or miss consensus estimates last quarter?

- **Strategic Growth Acceleration**: Adjacent markets (Home & Office, Medical) to contribute $50-100M+ annually by 2028, with ThermAffyx driving Medical segment doubling by 2030. 
- **Modine Synergies**: $25M+ annual cost savings and $100M+ commercial funnel expansion via valve integration in power gen and data centers. 
- **2026 Financial Targets**: 3%+ revenue growth, 12%+ EBITDA margin, $80-100M free cash flow. 
- **China Momentum**: Global OEMs in China increased take rates, supporting 820bps outperformance vs light vehicle production.

**【CEO Summary Section】**
- **Strategic Growth Initiatives**: Expanded into 4 core platforms (thermal management, air moving devices, pneumatic solutions, valve systems) to target non-automotive markets. Secured $300M+ lifetime revenue in adjacent markets (e.g., Home & Office, Medical) within 9 months of launch. 
- **Modine Merger**: $2.6B combined entity with $25M+ annual cost synergies. Leverages Modine's commercial vehicle and heavy-duty equipment relationships to accelerate Gentherm's valve business growth. 
- **Medical Innovation**: FDA 510(k) submission for ThermAffyx patient warming system, expected to generate $50-100M in revenue by 2028 and double the Medical segment by 2030. 
- **2026 Outlook**: 3%+ revenue growth (mid-single digits above market), with 12%+ EBITDA margin expansion driven by footprint optimization and adjacent market penetration. 

**【CFO Financial Commentary】**
- **2025 Results**: $1.5B revenue (+2.9% YoY), $175M adjusted EBITDA (11.7% margin). Automotive Climate Solutions outgrew light vehicle production by 820bps. 
- **2026 Guidance**: 
  - Revenue: $1.5-1.6B (midpoint +3% YoY)
  - EBITDA: $175-195M (12%+ margin)
  - Free Cash Flow: $80-100M
- **Key Drivers**: 60bps margin headwind from footprint transitions, offset by material cost savings and new program launches. 2027 revenue outlook of $1.7B (+10% YoY) reflects strong launch pipeline and adjacent market growth. 

**【Q&A Highlights】**
- **China Performance**: 60% of China awards from domestic OEMs, with global OEMs increasing take rates in 2025Q4. 
- **ThermAffyx Timeline**: FDA approval expected in 2026H1, with revenue contribution starting in 2026. 
- **Valve Expansion**: Modine's power generation and data center thermal management platforms create $100M+ commercial synergy opportunities for Gentherm valves. 
- **Margin Outlook**: 2027 EBITDA margin expansion driven by footprint completion, adjacent market mix shift, and Modine integration benefits.

Gentherm Incorporated (THRM) Q4 2025 Earnings Call Transcript

- **Revenue Growth**: Q3 revenue up 4.1% YoY to $387M, driven by 8.6% growth in automotive solutions. Full-year guidance raised to $1.47-1.49B.
- **Strategic Wins**: $745M Q3 new business awards, including 100% incremental Mercedes-Benz contract. 4th OEM adopts Pulse A massage tech.
- **Adjacent Market Expansion**: $300M commercial funnel with first furniture production in Q1 2026. Exploring India two-wheeler market with existing tech.
- **Financial Strength**: $88M operating cash flow YTD, 12.7% EBITDA margin. Net leverage at 0.2x, enabling strategic investments.
- **Risks Mitigated**: Actively managing supply chain disruptions (Novelis, Nexperia) with no direct impact to date.

**【CEO Summary Section】**
- **Record Revenue and Cash Flow**: Q3 revenue of $387 million, up 4.1% YoY, driven by automotive solutions growth of 8.6%. Operating cash flow of $88 million year-to-date.
- **Strategic Wins**: $745M new business awards (Q3) and $1.8B YTD, targeting $2B+ annual awards. Key win: 100% incremental Mercedes-Benz contract with Pulse A massage system, set to double annual lumbar/massage revenue post-2028 production.
- **Adjacent Market Expansion**: $300M commercial funnel across furniture, commercial vehicles, and mobility. First furniture production in Q1 2026, leveraging existing assets for minimal capital investment.
- **Operational Efficiency**: Global manufacturing footprint realignment (Tianjin, China; Morocco) on track for 2026 completion. Standardized operating system to enhance margins and cash flow.
- **Supply Chain Monitoring**: Actively mitigating risks from Novelis aluminum fire and Nexperia semiconductor issues, with no direct Gentherm impact yet.

**【CFO Financial Commentary】**
- **Financial Performance**: Adjusted EBITDA of $49M (12.7% margin), up 20 basis points YoY. Non-GAAP EPS of $0.73, despite headwinds from material costs and footprint transitions.
- **Guidance Update**: Full-year revenue raised to $1.47-1.49B (midpoint +$15M), driven by improved industry production. Narrowed EBITDA margin range to 11.9%-12.3%.
- **Cash Management**: Net leverage at 0.2x, enabling strategic investments. CapEx reduced to $45-55M, reflecting optimized capital allocation.

**【Q&A Highlights】**
- **Winning Strategy**: Innovation (Pulse A), direct OEM relationships, and value-added solutions key to conquest business. 4th global OEM adopts Pulse A since launch.
- **Adjacent Market Momentum**: Furniture and commercial vehicle opportunities expected to contribute $3-5M+ in 2026, with faster time-to-revenue than automotive.
- **India and Two-Wheelers**: Exploring thermal solutions for two-wheelers in India, leveraging existing tech for new market entry.
- **M&A Focus**: Seeking product expansion and market access aligned with core technologies, avoiding high-risk diversification.

Gentherm Incorporated (THRM) Q3 2025 Earnings Call Transcript

- **Strategic Win**: Secured $620M in Q2 new business, including full comfort solution on Ford's top-selling F-Series trucks.
- **Revenue Shift**: 70% of China awards with domestic OEMs vs. 50% historical, targeting 60-40 mix by next year.
- **Growth Engine**: Lumbar/massage product line to triple from $175M (2024) to >$300M (2027) with new program launches.
- **Adjacent Market Expansion**: 5 new wins in commercial vehicles and powersports, leveraging existing tech platforms.
- **Financial Outlook**: 2025 EBITDA margin 11.7-12.5%, with Q3 similar to Q2 despite industry production decline.

**【CEO Summary Section】**
- **Q2 Performance Highlights**: Adjusted EBITDA margin improved by 100+ basis points vs. Q1, with $620M in new business awards (year-to-date: $1B). Secured full comfort solution on Ford's F-Series trucks, a top North American vehicle platform.
- **Revenue Trends**: Automotive segment outperformed production in North America (+10 bps) and Europe, but underperformed in Asia. Shifting focus to Chinese domestic OEMs: 70% of Q2 China awards with domestic firms vs. 50% historical share.
- **Strategic Growth**: Lumbar/massage product line to grow from $175M (2024) to >$300M (2027). Expanded into 5 new adjacent market programs (e.g., commercial vehicles, powersports valves).
- **Operational Focus**: Standardizing processes across 5 manufacturing sites. On track to complete global footprint realignment by late 2026.

**【CFO Financial Commentary】**
- **Q2 Financials**: Revenue $-0.2% YoY, adjusted EBITDA $45.9M (12.2% margin vs. 13.3% last year). Margins impacted by higher material/labor costs and tariff timing delays (15 bps headwind).
- **Guidance Update**: 2025 revenue $1.43-1.5B, EBITDA margin 11.7-12.5%. Q3 expected similar to Q2 despite industry production decline, driven by new program launches.
- **Liquidity**: $416M available cash, $81M net debt. Repurchased $10M shares in Q2.

**【Q&A Highlights】**
- **Ford F-Series Win**: Secured all heat, lumbar, and massage systems pre-seat supplier selection, demonstrating direct OEM engagement strength.
- **Adjacent Markets**: 2 new commercial vehicle thermal solutions and 3 powersports valve awards. Valves seen as 'catalog parts' with quick deployment potential.
- **China Strategy**: Target 60-40 global/domestic OEM mix by next year. New programs launching in 6-18 months, faster than traditional automotive cycles.
- **Tariff Management**: Passing through costs with ~15 bps quarterly impact, stable customer production visibility.


Gentherm Incorporated (THRM) Q2 2025 Earnings Call Transcript

- **Resilient Execution Amid Volatility**: Maintained $1.45B revenue guidance despite 10% North America volume decline, supported by 1% ex-FX growth and 6% medical segment expansion.
- **Medical Market Breakthrough**: 2 new surgical warming system designs using existing automotive components, with positive customer feedback targeting $100M+ revenue opportunity.
- **Cost Control Excellence**: 0.5x net leverage, $99M net debt, and $11M capex invested in efficiency improvements.
- **Tariff Mitigation Success**: 90% of components exempt or USMCA-compliant, with full customer reimbursement for <100bps margin impact.

**【CEO Opening Remarks】**
- **Tariff Mitigation Strategy**: 40% of revenue from Mexico-based production, with 90% of components either exempt or USMCA-compliant. Tariffs passed through to customers via contractual agreements or logistics restructuring. 
- **New Business Wins**: $400M in Q1 automotive awards, including first Pneumatic Comfort Solutions win with a Japanese OEM and climate-controlled seat award with Volvo.
- **Medical Market Expansion**: 2 new proof-of-concept designs using existing automotive thermal management components for surgical warming systems. Voice-of-customer workshops indicate strong adoption potential.
- **Operational Optimization**: Consolidating manufacturing footprint (e.g., closing Czech Republic plant, shifting Shanghai production to Tianjin) to reduce costs and improve efficiency.

**【CFO Financial Highlights】**
- **Q1 Results**: Revenue $1.45B (flat YoY, +1% ex-FX). Adjusted EBITDA $39.3M (11.1% margin vs. 12.2% YoY). Medical segment revenue +6% ex-FX driven by European growth.
- **Key Drivers**: 
  - +380bps outperformance vs. industry vehicle production in Climate & Comfort Solutions
  - $11M net capex investment in manufacturing efficiency
  - $99M net debt (0.5x leverage)
- **2025 Guidance**: 
  - Revenue $1.45B-$1.55B (unchanged midpoint)
  - Adjusted EBITDA margin 11.5%-13.0% (lowered from 12.0%-14.0%)
  - 10% North America volume decline offset by FX favorability and tariff pass-through

**【Q&A Key Takeaways】**
1. **Tariff Impact**: 
   - <100bps margin dilution from tariffs
   - Full recovery via customer contracts
   - 40% of revenue exposed to North America production decline
2. **Medical Market Focus**: 
   - Leveraging existing automotive R&D investments (no incremental capital)
   - Targeting $100M+ medical revenue within 3 years
3. **Order Book Visibility**: 
   - Q1 awards in line with historical Q1 trends
   - Full-year pipeline remains robust despite industry uncertainty
4. **Supply Chain Resilience**: 
   - No stockpiling observed from customers
   - USMCA compliance eliminates 90% of tariff exposure

Gentherm (THRM)-24 Apr 25-2025 Q1 Earnings call transcript

- **2024 Success**: $2.4B new business wins, $183M EBITDA, 30% production footprint reduction plan.
- **2025 Growth**: 2% revenue growth (ex FX), 12-13% EBITDA margin target.
- **Key Initiatives**: Scaling core technologies, $50M+ restructuring costs, 40% China domestic OEM mix.
- **Risk Management**: Proactive tariff planning, Mexico supply chain focus.


**【CEO Opening Remarks】**
- Emphasized Gentherm's technology leadership across 4 core platforms: thermal management, air moving devices, pneumatic solutions, and valve systems.
- Highlighted 2024 achievements: $2.4B automotive new business awards, record $183M adjusted EBITDA, and 30% production footprint reduction plan.
- Key priorities: scaling core technologies, operational efficiency improvements, and strategic manufacturing consolidation.

**【CFO Financial Review】**
- 2024 Financials: Revenue $1.46B (down 0.9% YoY), adjusted EBITDA $183M (+30bps margin expansion). Medical segment revenue up 9% YoY.
- 2025 Outlook: Revenue $1.4-1.5B (+2% ex FX), adjusted EBITDA margin 12-13%. 
- Headwinds: $35M FX impact, $50M+ onetime costs from footprint restructuring.
- Cash flow: $110M operating cash flow in 2024, $70-80M 2025 capex.

**【Q&A Key Takeaways】**
- **Growth Drivers**: Pneumatic solutions (+20% 2024), CCS compact vent, BMW Pulse A awards. China domestic OEM mix target 40% vs 20% current.
- **Operational Efficiency**: 30% footprint reduction to improve margins. Fit-for-Growth 2.0 focuses on asset utilization and net working capital.
- **Risk Management**: Proactive tariff mitigation with customers. Mexico plants represent primary North American supply chain exposure.
- **Capital Allocation**: Prioritize organic growth, then M&A, with $120M remaining under share buyback authorization.


Actual											0.511	-0.3	0.91	1.16	1.04	0.85	0.51	0.61	0.41	0.25	0.7	0.47	0.49	0.58	0.64	0.9	0.62	0.66	0.75	0.29	0.51	0.54	0.73	0.49
Forecast											0.4533	-0.48	0.494	0.708	0.67	0.652	0.6843	0.3986	0.5167	0.422	0.52	0.615	0.5026	0.5201	0.6773	0.5006	0.4498	0.597	0.6467	0.6791	0.4652	0.5824	0.6511	0.56
Surprise	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	+12.73%	+37.50%	+84.21%	+63.84%	+55.22%	+30.37%	-25.47%	+53.04%	-20.65%	-40.76%	+34.62%	-23.58%	-2.51%	+11.52%	-5.51%	+79.78%	+37.84%	+10.55%	+15.97%	-57.30%	+9.63%	-7.28%	+12.12%	-12.50%

THRM

THRM fundamentals

THRM Q4 2025 Earnings

Earnings Call

You can ask Aime

THRM

THRM fundamentals

THRM Q4 2025 Earnings

Earnings Call

THRM Earnings Call Summary for Q4/20258:00 AM on Feb 19, 2026

THRM Earnings Call Summary for Q3/20258:00 AM on Oct 23, 2025

THRM Earnings Call Summary for Q2/20258:00 AM on Jul 24, 2025

THRM Earnings Call Summary for Q1/20258:00 AM on Apr 24, 2025

THRM Earnings Call Summary for Q4/20248:00 AM on Feb 19, 2025

You can ask Aime